Overview

A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes

Status:
Completed
Trial end date:
2019-05-06
Target enrollment:
Participant gender:
Summary
The purpose of this early feasibility study is to assess the predictive low glucose suspend (PLGS) feature's safety, functionality and performance.
Phase:
N/A
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Insulin
Insulin Lispro
Insulin, Globin Zinc